Drug combo curbs viral load in difficult-to-treat hepatitis C cases

08/27/2013 | DoctorsLounge.com · MedPage Today (free registration)

Sofosbuvir plus ribavirin showed efficacy in reducing viral load in patients infected with hepatitis C who are considered unlikely to respond to treatment, according to a study published in the Journal of the American Medical Association. No deaths were recorded, and no patients stopped treatment due to adverse events.

View Full Article in:

DoctorsLounge.com · MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC